Clinical Trial: Vepdegestrant vs Fulvestrant in ER+, HER2- Advanced Breast Cancer

Researchers are conducting a phase 3 trial to compare vepdegestrant to fulvestrant in patients with ER+, HER2- advanced breast cancer.

Related Keywords

,Arvinas Estrogen Receptor Inc ,Pfizer ,Arvinas Estrogen Receptor ,